Websites
- Hollmer M. Bioject mulls options including possible sale. www.fiercedrugdelivery.com/story/bioject-maker-needle-free-drug-delivery-systems-mulls-options-including-possible-sale/2012-01-
- Kedem Pharmaceuticals initiates development of sublingual anti-cancer drug, Gleevec®. www.bloomberg.com/article/2012-01-12/a515FXOF_KGk.html
- Clearside Biomedical launched with pipeline and technology focused on drugs delivered to the back of the eye 2012. www.businesswire.com/news/home/20120105005177/en/Clearside-Biomedical-Launched-Pipeline-Technology-Focused-Drugs
- Alnylam and Arrowhead Form Collaboration and Licensing Agreement. www.marketwatch.com/story/alnylam-and-arrowhead-form-collaboration-and-licensing-agreement-2012-01-05
- Lewis D. Dynamic polyconjugates technology: an elegant solution to the siRNA delivery problem. www.arrowres.com/pdf/Arrowhead-Research-Corporation_-_DPC-Technology-White-Paper-November2011.pdf
- Alnylam 5×15 Programs 2012. http://phx.corporate-ir.net/phoenix.zhtml?c=148005&p=irol-newsArticle&ID=1513530&highlight=
- Cameron N. Peptide-based nanoparticles as ocular drug delivery vehicles. www.vision-research.eu/index.php?id=85&tx_browser_pi1%5BshowUid%5D=2&cHash=c078925667
- Lamar M. BioDelivery to get up to $180M in Endo Pharma pact. Greenfield Reporter. www.marketwatch.com/story/biodelivery-to-get-up-to-180m-in-endo-pharma-pact-2012-01-06
- IntelGenx. IntelGenx announces development and commercialization agreement with par Pharmaceutical, Inc. Globe Newswire. http://webfarm.bloomberg.com/apps/news?pid=conewsstory&tkr=PRX:US&sid=aLa116AKXZVswww.intelgenx.com/investors/pressreleases/2011/2011-12-21.html
- Hollmer M. Carticept nails down $10M to fuel Q1 launch of ultrasound drug delivery system. www.fiercedrugdelivery.com/story/carticept-nails-down-10m-fuel-q1-launch-ultrasound-drug-delivery-system/2012-01-19
- Carticept Medical I. Carticept Medical closes $10 million series C sinancing round. www.fiercebiotech.com/press-releases/carticept-medical-closes-10-million-series-c-financing-round-0
- Pacira Pharmaceuticals I. Pacira Pharmaceuticals provides update on commercial Launch and product availability timing for EXPAREL®. http://investor.pacira.com/phoenix.zhtml?c=220759&p=irol-newsArticle&ID=1645752&highlight=
- US FDA. Ikaria INOmax DS Drug Delivery System: Class I recall – erratic nitric oxide readings. www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm285803.htm
- We understand patient bedside and transport needs. http://inomax.com/inomax-delivery-systems/inomax-ds/
- Abbott launches trial for Esprit vascular disease treatment. www.massdevice.com/news/abbott-launches-trial-esprit-vascular-disease-treatment
- Gillis S. Civitas therapeutics announces positive results from clinical study of CVT-301, an inhaled L-dopa for Parkinson‘s disease. www.bloomberg.com/article/2012-01-06/acUT6C1mebh4.html